BioDelivery Sciences International, Inc.

    Jurisdiction
    United States
    LEI
    529900YQ5QSV2ZNM2W45
    ISIN
    US09060J1060 (BDSI)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €142.19M
    Gross margin
    86.0%
    EBIT
    €31.67M
    EBIT margin
    22.3%
    Net income
    €72.38M
    Net margin
    50.9%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Belbuca €148.19M 104.2%
    Symproic €16.41M 11.5%

    Earnings Calls

    Latest earnings call: November 3, 2021

    Add to watchlist

    Notifications